FindTrial
Sign In

Development of a risk score for prediction of longer duration of citrate accumulation among patients receiving artificial liver support system therapy with regional citrate anticoagulation

Development of a risk score for prediction of longer duration of citrate accumulation among patients receiving artificial liver support system therapy with regional citrate anticoagulation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029179
Enrollment
Unknown
Registered
2020-01-17
Start date
2020-01-15
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver failure

Interventions

Gold Standard:Clinical outcome
Index test:risk&#32
score&#32
for&#32
prediction

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients recorded in a previously established clinical database from the Center of Infectious Diseases, West China Hospital of Sichuan University; 2. Patients treated with plasma adsorption plus plasma exchange therapy with regional citrate anticoagulation.

Exclusion criteria

Exclusion criteria: Patients with cancer.

Design outcomes

Primary

MeasureTime frame
Longer duration of citrate accumulation;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactYuanji Ma

West China Hospital, Sichuan University

maxe.doc@163.com+86 18081155515

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026